Stock Comparison
CRMD vs FMC
CorMedix Inc vs FMC Corp
The Verdict
CRMD takes this one.
Head-to-Head
Market Cap
P/E Ratio
Profit Margin
Return on Equity
Debt-to-Equity
Overall Risk
DVR Score
The Deep Dive
CorMedix Inc. maintains a strong investment thesis for 10x potential, underpinned by the recent (as per previous analysis) FDA approval of DefenCath. This approval has significantly de-risked the primary regulatory hurdle, opening up a substantial market for preventing catheter-related bloodstream infections in hemodialysis patients. The company benefits from a first-in-class designation and QIDP ...
Full CRMD AnalysisFMC Corporation operates in the mature and cyclical agricultural sciences industry, focusing on crop protection. The company's business model and market dynamics do not align with 10x growth potential within 3-5 years. Recent Q4 2025 earnings showed an 11.5% YoY revenue decline and a significant EPS drop, missing estimates. The Q1 2026 guidance projects negative EPS, and FY2026 guidance is substan...
Full FMC AnalysisWant More Comparisons?
Run any stock through our deep value analyzer.
Analyze Any Stock →Not Financial Advice
This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.